Cargando…

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors

The use of protease inhibitors in human immunodeficiency virus type 1 (HIV-1) treatment is limited by adverse effects, including metabolic complications. To address these challenges, efforts are underway in the pursuit of more potent and less toxic HIV-1 protease inhibitors. Repurposing existing dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okafor, Sunday N., Meyer, Abigail, Gadsden, Jay, Ahmed, Fadi, Guzmán, Lilian, Ahmed, Hashim, Romero, José A. Fernández, Angsantikul, Pavimol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488881/ https://www.ncbi.nlm.nih.gov/pubmed/37687159 http://dx.doi.org/10.3390/molecules28176330

Ejemplares similares

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques
por: Okafor, Sunday N., et al.
Publicado: (2022)

Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile
por: Gooyit, Major, et al.
Publicado: (2016)

Drug reprofiling history and potential therapies against Parkinson’s disease
por: Latif, Komal, et al.
Publicado: (2022)

Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
por: Angsantikul, Pavimol, et al.
Publicado: (2015)

NF-κB Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress—A Reprofiling Approach
por: Ali, Awais, et al.
Publicado: (2020)

Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics
por: del Ama, Laura Fernandez, et al.
Publicado: (2016)

Freeze-drying for the preservation of immunoengineering products
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

Retraction: NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—A reprofiling approach
Publicado: (2023)

Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds
por: Farag, Ahmed K., et al.
Publicado: (2019)

Topiramate Reprofiling for the Attenuation of Cadmium-Induced Testicular Impairment in Rats: Role of NLRP3 Inflammasome and AMPK/mTOR-Linked Autophagy
por: Arab, Hany H., et al.
Publicado: (2022)

Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
por: Ishii, Isao, et al.
Publicado: (2012)

Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling
por: Dilly, Suzanne J., et al.
Publicado: (2017)

Deep Eutectic Solvents for Subcutaneous Delivery of Protein Therapeutics
por: Curreri, Alexander M., et al.
Publicado: (2023)

Celastrol inhibits intestinal lipid absorption by reprofiling the gut microbiota to attenuate high-fat diet-induced obesity
por: Hua, Hu, et al.
Publicado: (2021)

Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera
por: Das, Soumita, et al.
Publicado: (2018)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

Native metabolomics identifies the rivulariapeptolide family of protease inhibitors
por: Reher, Raphael, et al.
Publicado: (2022)

The SAGA complex, together with transcription factors and the endocytic protein Rvs167p, coordinates the reprofiling of gene expression in response to changes in sterol composition in Saccharomyces cerevisiae
por: Dewhurst-Maridor, Gisèle, et al.
Publicado: (2017)

Inhibitors of HIV-1 and Cathepsin L Proteases Identified from the Insect Gall of Hypericum kouytchense
por: Pan, Bo Wen, et al.
Publicado: (2022)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Development of Mucoadhesive Electrospun Scaffolds for Intravaginal Delivery of Lactobacilli spp., a Tenside, and Metronidazole for the Management of Bacterial Vaginosis
por: Ilomuanya, Margaret O., et al.
Publicado: (2023)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
por: Youssef, Mahmoud E., et al.
Publicado: (2021)

Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities
por: Makgoo, Lilian, et al.
Publicado: (2022)

HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites
por: Alfonso, Yenisey, et al.
Publicado: (2011)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani, Imène, et al.
Publicado: (2013)

Applications of Click Chemistry in the Development of HIV Protease Inhibitors
por: Mudgal, Mukesh M., et al.
Publicado: (2018)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
por: Babrzadeh, Farbod, et al.
Publicado: (2013)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
por: Kann, Gerrit, et al.
Publicado: (2021)

Author correction: Micromotor-enabled active drug delivery for in vivo treatment of stomach infection
por: de Ávila, Berta Esteban-Fernández, et al.
Publicado: (2017)

Micromotor-enabled active drug delivery for in vivo treatment of stomach infection
por: de Ávila, Berta Esteban-Fernández, et al.
Publicado: (2017)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kau8i2ucr3s4ma9uuhp8vnii9e